Skip to main content Skip to main navigation menu Skip to site footer

24-year-old obese woman with dilated cardiomyopathy: a case report of obese cardiomyopathy


Background: Dilated cardiomyopathy is a disease characterized by enlargement of the heart ventricles with impaired left ventricular or biventricular systolic function. Obesity is a risk factor for changes in the structure and function of the heart, known as obese cardiomyopathy. The purpose of writing this case report is to holistically discuss obesity as a risk factor for dilated cardiomyopathy based on a literature review.

Case presentation: A 24-year-old woman complained of shortness of breath 2 months ago, appeared during activities and while she slept at night, and improved when sitting and resting. Other complaints are palpitations, swollen feet, nausea, and vomiting. Childhood history of obesity. Blood pressure 160/95 mmHg, respiratory rate 22 times/minute, and body mass index 33.8 kg/m2 (obesity II). The jugular venous pressure is increased. Auscultation revealed a systolic murmur at ICS 4 grade 3/6 and pulmonary crackles, with pitting edema in the legs. Electrocardiography revealed sinus tachycardia. Laboratory tests showed high triglycerides and total cholesterol, and other laboratories were within normal limits. Echocardiographic examination showed decreased left ventricular systolic function, severe left ventricular dilatation, and an ejection fraction of 27.9%. No significant lesions were found during the angiographic examination. A magnetic resonance imaging examination revealed non-ischemic cardiomyopathy, moderate left ventricular dysfunction, and severe right ventricular dysfunction. Patients were given heart failure therapy according to guidelines. On routine control, the patient's condition was stable.

Conclusion: Obesity is believed to be a risk factor for dilated cardiomyopathy through an increased hemodynamic load, neurohormonal dysregulation, inflammation, and lipotoxicity. Modalities such as the electrocardiogram, echocardiography, and magnetic resonance imaging can support the results of examinations for diagnosing dilated cardiomyopathy due to obesity. The management of obese cardiomyopathy involves changing lifestyles and administering drugs according to the clinical manifestations of heart failure.


  1. Lily S Leonard (eds) et al. Pathophysiology of Heart Disease: a collaborative project of medical students and faculty Fifth edition, 2011. Wolter Kluwer.
  2. Bozkurt B, Colvin M, Cook J, Cooper LT, Deswal A, Fonarow GC et al. Current Diagnostic and Treatment Strategis for Specific Dilated Cardiomyopathies: A Scientific Statement from The American Heart Association. AHA Clinical Statement and Guideline 2016; 134(23):579-e646.
  3. Hazebroek M, Dennert R, Heymans S. Idiopathic dilated Cardiomyopathy: Possible triggers and Treatment Strategies. ICIN Netherland Health Institute. 2012;20:332-5.
  4. Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A et al. Hearth Failure in Africa, Asia, the middle east and South America: The INTER-CHF Study. International Journal of Cardiology. 2015:204: 133-141
  5. Verdonschot J, Hazebroek M, Ware J. Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach. Journal of the American Heart Association. 2019.
  6. Schultheiss HP, Fairweather D, Caforio AL, Escher F, Hershberger RE, Lipshultz SE et al. Dilated Cardiomyopathy. Nature Reviews Disease Primers. 2019;5(1):32.
  7. Japp AG, Gulati A, Cook SA, Cowie MR, Prasad SK. The diagnosis and evaluation of dilated cardiomyopathy. Journal of the American college of cardiology. 2016;67(25):2996-3010.
  8. Alpert MA, Karthikeyan K, Abdullah O, Ghadban R. Obesity and cardiac remodeling in adults: mechanisms and clinical implications. Prog Cardiovasc Dis. 2018; 61:114–123.
  9. Manojan, K., Benny, P., & Bindu, A. Prevalence of Obesity and Overweight among Medical Students based on New Asia-Pacific BMI Guideline. Kerala Medical Journal, 2019; 12(1):13-15.
  10. Robertson J, Lindgren M, Schaufelberger M, Adiels M, Björck L, Lundberg CE, et al. Body mass index in young women and risk of cardiomyopathy: a long-term follow-up study in Sweden. Circulation. 2020; 141:520–9.
  11. Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016; 118: 1752–1770.
  12. Packer M. Derangements in adrenergic-adipokine signalling establish a neurohormonal basis for obesity-related heart failure with a preserved ejection fraction.Eur J Heart Fail. 2018; 20:873–878.
  13. Sletten AC, Peterson LR, Schaffer JE. Manifestations and mechanisms of myocardial lipotoxicity in obesity. J Intern Med. 2018; 284:478–491.
  14. Alpert MA, Omran J, Mehra A, Ardhanari S. Impact of obesity and weight loss on cardiac performance and morphology in adults. Prog Cardiovasc Dis. 2014; 56:391–400.
  15. Alpert MA, Lavie CJ, Agrawal H, Aggarwal KB, Kumar SA. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management. Translational Research. 2014; 164(4), 345–56.
  16. Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity Cardiomyopathy: Evidence, Mechanisms, And Therapeutic Implications. Physiol Rev. 2021; 101:1745–1807.
  17. Weintraub RG, Semsarian C, Macdonald P. Dilated cardiomyopathy. The Lancet. 2017;390(10092):400-14.

How to Cite

Wikananda, G. D. D., Gumilang, P. G. A. ., & Suwirya, A. P. . (2023). 24-year-old obese woman with dilated cardiomyopathy: a case report of obese cardiomyopathy. Intisari Sains Medis, 14(1), 280–284.




Search Panel

Gede Dehandra Dipastraya Wikananda
Google Scholar
ISM Journal

Putu Gupta Arya Gumilang
Google Scholar
ISM Journal

Agung Pradnyana Suwirya
Google Scholar
ISM Journal